{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:43:12Z","timestamp":1790516592168,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18K11679"],"award-info":[{"award-number":["18K11679"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15H02480"],"award-info":[{"award-number":["15H02480"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15H02480"],"award-info":[{"award-number":["15H02480"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Fibrillin-1<\/jats:italic> (<jats:italic>FBN1<\/jats:italic>) is responsible for haploinsufficient and autosomal dominant Marfan syndrome. Even in the same Marfan pedigree, penetrance and expressivity in heterozygous individuals can differ and result in variable disease onset and severity. Thus, other factors in addition to mutations in <jats:italic>FBN1<\/jats:italic> are likely to contribute to the disease. In this study, we examined the regulation of <jats:italic>FBN1<\/jats:italic> in porcine Marfan syndrome model, focusing on DNA methylation patterns distinguishable as wild-type (WT) and <jats:italic>FBN1<\/jats:italic> null (KO) alleles in heterozygous cells. Most importantly, the ratio of the transcriptionally active hypomethylated WT allele was altered during cellular passage and highly correlated with <jats:italic>FBN1<\/jats:italic> mRNA level compared with that in the KO allele. Transcribed <jats:italic>FBN1<\/jats:italic> RNA from the KO allele was abolished after splicing coupled with translational initiation, suggesting that the functional <jats:italic>FBN1<\/jats:italic> mRNA levels were affected by DNA methylation of the WT allele.<\/jats:p>","DOI":"10.1038\/s41598-020-62127-3","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T11:06:27Z","timestamp":1585047987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["DNA methylation ambiguity in the Fibrillin-1 (FBN1) CpG island shore possibly involved in Marfan syndrome"],"prefix":"10.1038","volume":"10","author":[{"given":"Yoshikazu","family":"Arai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Umeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ohgane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"62127_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1172\/JCI200420641","volume":"114","author":"DP Judge","year":"2004","unstructured":"Judge, D. P. et al. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J. Clin. Invest. 114, 172\u2013181 (2004).","journal-title":"J. Clin. Invest."},{"key":"62127_CR2","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/hrt.2010.212100","volume":"97","author":"G Jondeau","year":"2011","unstructured":"Jondeau, G. et al. The translational science of Marfan syndrome. Heart 97, 1206\u20131214 (2011).","journal-title":"Heart"},{"key":"62127_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/humu.10113","volume":"20","author":"PN Robinson","year":"2002","unstructured":"Robinson, P. N. et al. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum. Mutat. 20, 153\u2013161 (2002).","journal-title":"Hum. Mutat."},{"key":"62127_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000347163","volume":"4","author":"KJ Potter","year":"2013","unstructured":"Potter, K. J. et al. The c.7409G > A (p.Cys2470Tyr) Variant of FBN1: Phenotypic Variability across Three Generations. Mol. Syndromol. 4, 125\u2013135 (2013).","journal-title":"Mol. Syndromol."},{"key":"62127_CR5","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/hmg\/ddv037","volume":"24","author":"M Aubart","year":"2015","unstructured":"Aubart, M. et al. The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele. Hum. Mol. Genet. 24, 2764\u20132770 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"62127_CR6","doi-asserted-by":"publisher","first-page":"15641","DOI":"10.1073\/pnas.95.26.15641","volume":"95","author":"DL Cook","year":"1998","unstructured":"Cook, D. L. et al. Modeling stochastic gene expression: implications for haploinsufficiency. Proc. Natl Acad. Sci. USA 95, 15641\u201315646 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"62127_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/srep24413","volume":"6","author":"K Umeyama","year":"2016","unstructured":"Umeyama, K. et al. Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts. Sci. Rep. 6, 24413 (2016).","journal-title":"Sci. Rep."},{"key":"62127_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000078205","volume":"105","author":"K Shiota","year":"2004","unstructured":"Shiota, K. DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet. Genome Res. 105, 325\u2013334 (2004).","journal-title":"Cytogenet. Genome Res."},{"key":"62127_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000091922","volume":"114","author":"JD Lieb","year":"2006","unstructured":"Lieb, J. D. et al. Applying whole-genome studies of epigenetic regulation to study human disease. Cytogenet. Genome Res. 114, 1\u201315 (2006).","journal-title":"Cytogenet. Genome Res."},{"key":"62127_CR10","doi-asserted-by":"crossref","unstructured":"Ohgane, J.\u00a0et al. Epigenetics: the DNA methylation profile of tissue-dependent and differentially methylated regions in cells. Placenta 29, S29\u201335 (2008).","DOI":"10.1016\/j.placenta.2007.09.011"},{"key":"62127_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.1063443","volume":"293","author":"W Reik","year":"2001","unstructured":"Reik, W. et al. Epigenetic reprogramming in mammalian development. Science 293, 1089\u20131093 (2001).","journal-title":"Science"},{"key":"62127_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1046\/j.1365-2443.2002.00574.x","volume":"7","author":"K Shiota","year":"2002","unstructured":"Shiota, K. et al. Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes. Cell 7, 961\u2013969 (2002).","journal-title":"Genes. Cell"},{"key":"62127_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/j.1365-2443.2007.01120.x","volume":"12","author":"H Sakamoto","year":"2007","unstructured":"Sakamoto, H. et al. Cell type-specific methylation profiles occurring disproportionately in CpG-less regions that delineate developmental similarity. Genes Cells 12, 1123\u20131132 (2007).","journal-title":"Genes Cells"},{"key":"62127_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/dvg.22423","volume":"51","author":"Y Arai","year":"2013","unstructured":"Arai, Y. et al. DNA methylation profiles provide a viable index for porcine pluripotent stem cells. Genesis 51, 763\u2013776 (2013).","journal-title":"Genesis"},{"key":"62127_CR15","doi-asserted-by":"publisher","first-page":"e0146498","DOI":"10.1371\/journal.pone.0146498","volume":"11","author":"Y Arai","year":"2016","unstructured":"Arai, Y. et al. Ultra-Deep Bisulfite Sequencing to Detect Specific DNA Methylation Patterns of Minor Cell Types in Heterogeneous Cell Populations: An Example of the Pituitary Tissue. PLoS One 11, e0146498 (2016).","journal-title":"PLoS One"},{"key":"62127_CR16","first-page":"e002058","volume":"11","author":"N Takeda","year":"2018","unstructured":"Takeda, N. et al. Impact of pathogenic FBN1 variant types on the progression of aortic disease in patients with Marfan syndrome. Circ. Genom. Precis. Med. 11, e002058 (2018).","journal-title":"Circ. Genom. Precis. Med."},{"key":"62127_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1262\/jrd.2016-158","volume":"63","author":"Y Arai","year":"2017","unstructured":"Arai, Y. et al. Establishment of DNA methylation patterns of the Fibrillin1 (FBN1) gene in porcine embryos and tissues. J. Reprod. Dev. 63, 157\u2013165 (2017).","journal-title":"J. Reprod. Dev."},{"key":"62127_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0006-2952(97)00287-6","volume":"54","author":"T Ashikaga","year":"1997","unstructured":"Ashikaga, T. et al. Altered expression of cyclic nucleotide phosphodiesterase isozymes during culture of aortic endothelial cells. Biochem. Pharmacol. 54, 1071\u20131079 (1997).","journal-title":"Biochem. Pharmacol."},{"key":"62127_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-016-0176-7","volume":"14","author":"S Danesh Mesgaran","year":"2016","unstructured":"Danesh Mesgaran, S. et al. mRNA expression pattern of selected candidate genes differs in bovine oviductal epithelial cells in vitro compared with the in vivo state and during cell culture passages. Reprod. Biol. Endocrinol. 14, 44 (2016).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"62127_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12890-018-0652-2","volume":"18","author":"SR Reeves","year":"2018","unstructured":"Reeves, S. R. et al. Stability of gene expression by primary bronchial epithelial cells over increasing passage number. BMC Pulm. Med. 18, 91 (2018).","journal-title":"BMC Pulm. Med."},{"key":"62127_CR21","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1083\/jcb.103.6.2499","volume":"103","author":"LY Sakai","year":"1986","unstructured":"Sakai, L. Y. et al. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J. Cell Biol. 103, 2499\u20132509 (1986).","journal-title":"J. Cell Biol."},{"key":"62127_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0014-5793(96)00325-0","volume":"384","author":"Pfaff","year":"1996","unstructured":"Pfaff, M.\u00a0et al. Cell adhesion and integrin binding to recombinant human fibrillin-1. FEBS Lett. 384, 247\u2013250 (1996).","journal-title":"FEBS Lett."},{"key":"62127_CR23","doi-asserted-by":"publisher","first-page":"e1002085","DOI":"10.1371\/journal.pgen.1002085","volume":"7","author":"K Nishino","year":"2011","unstructured":"Nishino, K. et al. DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet. 7, e1002085 (2011).","journal-title":"PLoS Genet."},{"key":"62127_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1349-7006.2005.00035.x","volume":"96","author":"T Ushijima","year":"2005","unstructured":"Ushijima, T. & Okochi-Takada, E. Aberrant methylations in cancer cells: where do they come from? Cancer Sci. 96, 206\u2013211 (2005).","journal-title":"Cancer Sci."},{"key":"62127_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1017\/S000711451800243X","volume":"120","author":"K ElGendy","year":"2018","unstructured":"ElGendy, K. et al. Effects of dietary interventions on DNA methylation in adult humans: systematic review and meta-analysis. Br. J. Nutr. 120, 961\u2013976 (2018).","journal-title":"Br. J. Nutr."},{"key":"62127_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1262\/jrd.20038","volume":"54","author":"M Kurome","year":"2008","unstructured":"Kurome, M. et al. Production efficiency and telomere length of the cloned pigs following serial somatic cell nuclear transfer. J. Reprod. Dev. 54, 254\u2013258 (2008).","journal-title":"J. Reprod. Dev."},{"key":"62127_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.5966\/sctm.2012-0154","volume":"2","author":"H Tateno","year":"2013","unstructured":"Tateno, H. et al. Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN. Stem Cell Transl. Med. 2, 265\u2013273 (2013).","journal-title":"Stem Cell Transl. Med."},{"key":"62127_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.reth.2018.08.002","volume":"9","author":"K Nishino","year":"2018","unstructured":"Nishino, K. et al. Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectors. Regen. Ther. 9, 71\u201378 (2018).","journal-title":"Regen. Ther."},{"key":"62127_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s13577-017-0190-x","volume":"31","author":"K Takasawa","year":"2018","unstructured":"Takasawa, K. et al. DNA hypermethylation enhanced telomerase reverse transcriptase expression in human-induced pluripotent stem cells. Hum. Cell 31, 78\u201386 (2018).","journal-title":"Hum. Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62127-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:37:45Z","timestamp":1670315865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62127-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62127"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62127-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"19 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5287"}}